Doctor Patrick Moriarty
University of Kansas Medical Center, Kansas City (United States of America)
Member of:
/f/125658/4843x1496/b9b684dbb2/eapc-acronym-name-rgb.png)
The change in HDL proteomics following lipid-apheresis therapy
Event: ESC Congress 2018
Topic: Lipids, Other
Session: Preventive cardiology / Lipids
Efficacy and Safety of Evolocumab Compared With Continued Lipoprotein Apheresis: Results of a Randomised, Controlled, Open-Label Study
Event: ESC Congress 2017
Topic: Lipids (Epidemiology and Prevention)
Session: Late-Breaking Science Posters
ESCAPE - Effect of alirocumab on the frequency of lipoprotein apheresis: a randomised Phase III trial
Event: ESC Congress 2016
Topic: Lipids
Session: Hot Line prevention and lipids
Pitavastatin lowers plasma levels of CoQ10 less than equipotent doses of rosuvastatin or atorvastatin
Event: ESC Congress 2016
Topic: Lipids
Session: Cardiovascular cell biology
ESC 365 is supported by
